Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
Tesla and SpaceX CEO Elon Musk has hinted at the potential for Neuralink, his brain-machine interface company, to develop an implant for early-stage Alzheimer’s disease. He suggests focusing on alleviating back and neck pain with the technology, while also acknowledging the potential for limited help in later stages of Alzheimer’s due to extensive neuronal loss.
